Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-24-008827
Filing Date
2024-12-26
Accepted
2024-12-26 09:35:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4196
  Complete submission text file 0001959173-24-008827.txt   5807
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Subject) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 000-24006 | Film No.: 241577238
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1613 RAY DRIVE BURLINGAME CA 94010
Business Address
Wilson Mark Andrew (Reporting) CIK: 0001808356 (see all company filings)

Type: 144